Search

Author/Creator Kaplan, Z.

1. A time‐driven, activity‐based costing methodology for determining the costs of red blood cell transfusion in patients with beta thalassaemia major. Issue 1 (10th April 2018)

Authors:
Burns, K. E.; Haysom, H. E.; Higgins, A. M.; Waters, N.; Tahiri, R.; Rushford, K.; Dunstan, T.; Saxby, K.; Kaplan, Z.; Chunilal, S.; McQuilten, Z. K.; Wood, E. M.
Journal:
Transfusion medicine
Issue:
Volume 29:Issue 1(2019:Feb.)
Page Start:
33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. S291: PHASE I/II STUDY OF RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: LONG-TERM FOLLOW-UP. (23rd June 2022)

Authors:
Kuter, D. J.; Efraim, M.; Kaplan, Z.; Mayer, J.; Choi, P.; Jansen, A. G.; McDonald, V.; Baker, R.; Bird, R.; Garg, M.; Gumulec, J.; Kostal, M.; Gernsheimer, T.; Ghanima, W.; Yao, M.; Daak, A.; Cooper, N.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
192
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗